2,3-Diarylbenzopyran derivatives as a novel class of selective cyclooxygenase-2 inhibitors.
暂无分享,去创建一个
M. Noh | Shin Chung | Yung Hyup Hyup | Jin Kwan Kwan | Seon-Hwa Kang | Min-Soo Noh | Jun-Yong Ha | Jin Kyu Kyu | Kyung Min Min | Chang Hoon Hoon | J. Ha | Seon-Hwa Kang | S. Chung | J. Kyu | Chang Hoon
[1] C. Koboldt,et al. N-[[(5-methyl-3-phenylisoxazol-4-yl)-phenyl]sulfonyl]propanamide, sodium salt, parecoxib sodium: A potent and selective inhibitor of COX-2 for parenteral administration. , 2000, Journal of medicinal chemistry.
[2] G. Smith,et al. Metabolism of apigenin and related compounds in the rat. Metabolite formation in vivo and by the intestinal microflora in vitro. , 1972, The Biochemical journal.
[3] C. Koboldt,et al. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. , 1997, Journal of medicinal chemistry.
[4] N. Miyaura,et al. Novel synthesis of isoflavones by the palladium-catalyzed cross-coupling reaction of 3-bromochromones with arylboronic acids or its esters. , 1988 .
[5] S. Higuchi,et al. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. , 1993, General pharmacology.
[6] D. Dewitt,et al. Cox-2-selective inhibitors: the new super aspirins. , 1999, Molecular pharmacology.
[7] R. S. Rogers,et al. 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2. , 2000, Journal of medicinal chemistry.
[8] R. Erikson,et al. Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] Norio Miyaura,et al. The Palladium-Catalyzed Cross-Coupling Reaction of Phenylboronic Acid with Haloarenes in the Presence of Bases , 1982 .
[10] C. Thiemermann,et al. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[11] J. Bishop,et al. A simple inflammation model that distinguishes between the actions of anti-inflammatory and anti-rheumatic drugs , 1998, Inflammation Research.
[12] Hiromasa Hashimoto,et al. 4-(4-cycloalkyl/aryl-oxazol-5-yl)benzenesulfonamides as selective cyclooxygenase-2 inhibitors: enhancement of the selectivity by introduction of a fluorine atom and identification of a potent, highly selective, and orally active COX-2 inhibitor JTE-522(1). , 2002, Journal of medicinal chemistry.
[13] 2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors. , 2001, Bioorganic & medicinal chemistry letters.
[14] K. Seibert,et al. The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. , 1990, The Journal of biological chemistry.